LPL Financial
LCTX icon

LPL Financial’s Lineage Cell Therapeutics LCTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$21.8K Sell
24,074
-8,598
-26% -$7.8K ﹤0.01% 5305
2025
Q1
$14.8K Buy
32,672
+2,080
+7% +$939 ﹤0.01% 5151
2024
Q4
$15.4K Sell
30,592
-142
-0.5% -$71 ﹤0.01% 5100
2024
Q3
$27.8K Sell
30,734
-785
-2% -$711 ﹤0.01% 4951
2024
Q2
$31.4K Sell
31,519
-9,996
-24% -$9.97K ﹤0.01% 4793
2024
Q1
$61.4K Sell
41,515
-39,499
-49% -$58.5K ﹤0.01% 4669
2023
Q4
$88.3K Sell
81,014
-14,986
-16% -$16.3K ﹤0.01% 4510
2023
Q3
$113K Sell
96,000
-20,000
-17% -$23.6K ﹤0.01% 4336
2023
Q2
$164K Sell
116,000
-14,041
-11% -$19.8K ﹤0.01% 4160
2023
Q1
$195K Sell
130,041
-20,514
-14% -$30.8K ﹤0.01% 4029
2022
Q4
$176K Sell
150,555
-38,765
-20% -$45.4K ﹤0.01% 4000
2022
Q3
$214K Sell
189,320
-50,000
-21% -$56.5K ﹤0.01% 3842
2022
Q2
$378K Buy
239,320
+82,490
+53% +$130K ﹤0.01% 3420
2022
Q1
$242K Buy
156,830
+47,039
+43% +$72.6K ﹤0.01% 3710
2021
Q4
$269K Buy
109,791
+22,211
+25% +$54.4K ﹤0.01% 3747
2021
Q3
$221K Buy
87,580
+27,200
+45% +$68.6K ﹤0.01% 3869
2021
Q2
$172K Buy
60,380
+12,746
+27% +$36.3K ﹤0.01% 3926
2021
Q1
$112K Buy
47,634
+22,561
+90% +$53K ﹤0.01% 3878
2020
Q4
$44K Buy
25,073
+1,014
+4% +$1.78K ﹤0.01% 3719
2020
Q3
$23K Sell
24,059
-1,590
-6% -$1.52K ﹤0.01% 3475
2020
Q2
$22K Buy
25,649
+10,024
+64% +$8.6K ﹤0.01% 3380
2020
Q1
$13K Sell
15,625
-1,689
-10% -$1.41K ﹤0.01% 3158
2019
Q4
$15K Sell
17,314
-388
-2% -$336 ﹤0.01% 3300
2019
Q3
$17K Sell
17,702
-38,500
-69% -$37K ﹤0.01% 3254
2019
Q2
$62K Sell
56,202
-41
-0.1% -$45 ﹤0.01% 3172
2019
Q1
$74K Buy
56,243
+4,739
+9% +$6.24K ﹤0.01% 3073
2018
Q4
$47K Buy
51,504
+40,850
+383% +$37.3K ﹤0.01% 2992
2018
Q3
$25K Buy
10,654
+500
+5% +$1.17K ﹤0.01% 3179
2018
Q2
$21K Buy
+10,154
New +$21K ﹤0.01% 3157
2015
Q3
Sell
-14,227
Closed -$52K 2852
2015
Q2
$52K Buy
14,227
+3
+0% +$11 ﹤0.01% 2803
2015
Q1
$70K Buy
+14,224
New +$70K ﹤0.01% 2705